Press Releases

Press Releases

or

May 13, 2015
4 novel oncology candidates expected to be in clinical trials by end of 2015, including PD-1 monoclonal antibody Grand Cayman, May 13th, 2015,— BeiGene Ltd., an innovative oncology company focused on developing targeted and immuno-oncology therapeutics, today announced the successful completion of
April 7, 2015
Philadelphia, PA, April 7, 2015 — BeiGene Ltd., an innovative oncology company focused on developing targeted and immune-oncology therapeutics, today announced that company scientists and advisors will be presenting seven abstracts at the 106th Annual Meeting of the American Association for Cancer